Light chain amyloidosis is a plasma–cell disorder with a poor prognosis. It is a progressive
condition, causing worsening pain, disability, and life-limiting complications involving …

Light chain (AL) amyloidosis is a disease in which clonal plasma cells produce misfolded
light chains that then deposit in organs and impair their function. Amyloidosis is a …

Light chain (AL) amyloidosis is a rare plasma cell dyscrasia. An estimated 12,000 people
live with the disease in the United States. AL amyloidosis occurs from the misfolding of …

Immunoglobulin light chain (AL) amyloidosis is a disorder of clonal plasma cells
characterized by deposition of amyloid fibrils in a variety of tissues, leading to end-organ …

Light chain (AL) amyloidosis is a plasma cell dyscrasia characterized by the pathologic
production of fibrillar proteins comprised of monoclonal light chains which deposit in tissues …

Systemic immunoglobulin light chain (AL) amyloidosis is a disorder characterized by the
production of clonal serum free light chains that misfold, aggregate, and deposit in vital …

BACKGROUND: Primary systemic light-chain (AL) amyloidosis is a rare clonal plasma cell
disorder characterized by the production of abnormal immunoglobulin fragments, which form …

Amyloid light chain (AL) amyloidosis is a clonal plasma cell disorder leading to production of
misfolded monoclonal immunoglobulin light chains which result in organ damage, most …

Background: Light chain (AL) amyloidosis is a rare plasma cell neoplasm associated with
systemic amyloid deposition leading to organ dysfunction and death without treatment. The …

Systemic light chain (AL) amyloidosis is caused by a B-cell (most commonly plasma cell)
clone that produces a toxic light chain that forms amyloid fibrils in tissues and causes …